HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of small intestinal submucosa extracellular matrix in advanced regenerative wound therapy.

Abstract
Advanced regenerative therapies using cellular and tissue-based products (CTPs) can play an important role in effective management of hard-to-heal wounds. CTPs derived from allogenic or xenogenic tissues use an extracellular matrix (ECM) to provide a therapeutic ECM scaffold in the wound bed to facilitate tissue regeneration. One such example is OASIS Extracellular Matrix (Cook Biotech Incorporated), a porcine small intestinal submucosa extracellular matrix (SIS-ECM) that preclinical and clinical data have shown to be tolerable and effective in promoting tissue regeneration in hard-to-heal wounds.
AuthorsRichard Simman
JournalJournal of wound care (J Wound Care) Vol. 32 Issue Sup2 Pg. S3-S10 (Jan 01 2023) ISSN: 0969-0700 [Print] England
PMID36724085 (Publication Type: Journal Article)
Topics
  • Animals
  • Swine
  • Tissue Scaffolds
  • Intestine, Small
  • Extracellular Matrix
  • Wound Healing
  • Cell Proliferation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: